InsidersTradesSigma
Explore the full record of transactions filed by Dahan Michel, Chief Executive Officer. Officer active across 1 companies, notably Akebia Therapeutics, Inc.. Aggregated, 1 disclosures have been recorded. Total volume traded: €13k. The latest transaction was disclosed on 28 February 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
Michel Dahan is the Chief Operating Officer and Senior Vice President of Akebia Therapeutics, Inc. In this role, he oversees the company's operations and is responsible for optimizing processes to ensure maximum efficiency. Dahan has extensive experience in the biopharmaceutical sector, enabling him to lead strategic initiatives to enhance Akebia's performance. His leadership is crucial for achieving the company's operational and financial objectives.